story of the week
Patient-Reported Outcomes From the IMpassion130 Trial of Atezolizumab Plus Nab-Paclitaxel in Metastatic Triple-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology